Anti-Dynamin 1 antibody [EP801Y]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(17 Publications)
Rabbit Recombinant Monoclonal Dynamin 1 antibody. Suitable for WB, IHC-P and reacts with Mouse, Rat, Human samples. Cited in 17 publications.
View Alternative Names
DNM, DNM1, Dynamin-1, Dynamin, Dynamin I
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Dynamin 1 antibody [EP801Y] (AB52611)
Unpurified ab52611 at 1/100-1/250 dilution staining human brain tissue; paraffin embedded.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Dynamin 1 antibody [EP801Y] (AB52611)
Immunohistochemical staining of paraffin embedded human cerebral cortex with purified ab52611 at a working dilution of 1/50. The secondary antibody used is HRP goat anti-rabbit IgG H&L (ab97051) at 1/500. The sample is counter-stained with hematoxylin. Antigen retrieval was perfomed using Tris-EDTA buffer, pH 9.0. PBS was used instead of the primary antibody as the negative control, and is shown in the inset.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Dynamin 1 antibody [EP801Y] (AB52611)
Immunohistochemical staining of paraffin embedded mouse cerebral cortex with purified ab52611 at a working dilution of 1/50. The secondary antibody used is HRP goat anti-rabbit IgG H&L (ab97051) at 1/500. The sample is counter-stained with hematoxylin. Antigen retrieval was perfomed using Tris-EDTA buffer, pH 9.0. PBS was used instead of the primary antibody as the negative control, and is shown in the inset.
- WB
Lab
Western blot - Anti-Dynamin 1 antibody [EP801Y] (AB52611)
Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-Dynamin 1 antibody [EP801Y] (ab52611) at 1/10000 dilution
All lanes:
SH-SY5Y cell lysate at 10 µg
Secondary
All lanes:
HRP goat anti-rabbit IgG (H+L) at 1/50000 dilution
Predicted band size: 97 kDa
Observed band size: 97 kDa
false
- WB
Collaborator
Western blot - Anti-Dynamin 1 antibody [EP801Y] (AB52611)
ab52611 was shown to react with DNM1 in wild-type U-2 OS cells in Western blot with loss of signal observed in a DNM1 knockout cell line. Wild-type U-2 OS and DNM1 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab52611 overnight at 4 °C at a 1/1000 dilution. Blots were incubated with goat anti-rabbit HRP secondary antibodies at 0.2ug/mL before imaging. These data were provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes:
Western blot - Anti-Dynamin 1 antibody [EP801Y] (ab52611) at 1/1000 dilution
Lane 1:
Wild-type U-2 OS cell lysate at 20 µg
Lane 2:
DNM1 knockout U-2 OS cell lysate at 20 µg
Predicted band size: 97 kDa
false
- WB
Unknown
Western blot - Anti-Dynamin 1 antibody [EP801Y] (AB52611)
All lanes:
Western blot - Anti-Dynamin 1 antibody [EP801Y] (ab52611) at 1/2000 dilution
All lanes:
3T3 cell lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP antibody at 1/2000 dilution
Predicted band size: 84 kDa,97 kDa
Observed band size: 88 kDa,97 kDa
false
- WB
Lab
Western blot - Anti-Dynamin 1 antibody [EP801Y] (AB52611)
Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-Dynamin 1 antibody [EP801Y] (ab52611) at 1/2000 dilution
Lane 1:
C6 cell lysate at 20 µg
Lane 2:
NIH/3T3 cell lysate at 20 µg
Secondary
All lanes:
HRP goat anti-rabbit IgG (H+L) at 1/1000 dilution
Predicted band size: 97 kDa
Observed band size: 97 kDa
false
- WB
CiteAb
Western blot - Anti-Dynamin 1 antibody [EP801Y] (AB52611)
Dynamin 1 western blot using anti-Dynamin 1 antibody [EP801Y] ab52611. Publication image and figure legend from Ackermann, F., Schink, K. O., et al., 2019, Elife, PubMed 31074746.
ab52611 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab52611 please see the product overview.
Transposon mutagenesis leads to the loss of Piccolo protein in rats.(A) Schematic of transposon insertion into exon 3 of Pclo genomic sequence creating a translational stop codon, truncating the generation of long Piccolo isoforms. (B) PCR verification of genotypes. PCR from Pclowt/wt, Pclowt/gt and Pclogt/gt genomic DNA results in the amplification of 260 bp WT and/or 450 bp KO specific bands, respectively. (C and D) Western blot analysis of P0-P2 brain lysates (C) and lysates from DIV14 cultured hippocampal neurons (D). Bands, corresponding to Piccolo isoforms (70–560 kDa), are detected in Pclowt/wt and Pclowt/gt brain lysates as well as Pclowt/wt neuron lysates, but not in Pclogt/gt lysates (n = 3 independent experiments). (E) Immunocytochemical staining of hippocampal neurons. Piccolo immuno-reactivity co-localizes with VGlut1 in Pclowt/wt neurons, but not in Pclogt/gt neurons. Right panel, quantification of Piccolo intensities at VGlut1 puncta (Pclowt/wt = 1 ± 0.03, n = 586 synapses; Pclogt/gt = 0.35 ± 0.01, n = 718 synapses; two independent experiments). (F) Immuno-histological staining of Pclowt/wt and Pclogt/gt brain sections. Representative images from the CA1 region of the hippocampus are shown. No Piccolo immuno-reactivity can be observed on Pclogt/gt sections. (G) Western blot analysis of P0-P2 brain lysates. Expression levels of synaptic proteins are altered in Pclogt/gt brain lysates (EEA1 : Pclowt/wt = 1 ± 0.03, Pclowt/gt = 0.44 ± 0.01, Pclogt/gt = 0.50 ± 0.02; two independent experiments; Rab7 : Pclowt/wt = 1 ± 0.08, Pclowt/gt = 1.23 ± 0.05, Pclogt/gt = 0.83 ± 0.13; four independent experiments; Rab5 : Pclowt/wt = 1 ± 0.09, Pclowt/gt = 1.04 ± 0.11, Pclogt/gt = 1.22 ± 0.04; three independent experiments; Bassoon : Pclowt/wt = 1 ± 0.07, Pclowt/gt = 0.95 ± 0.16, Pclogt/gt = 0.80 ± 0.16; four independent experiments; Synaptophysin : Pclowt/wt = 1 ± 0.11, Pclowt/gt = 0.86 ± 0.13, Pclogt/gt = 0.82 ± 0.21; three independent experiments; VGlut1 : Pclowt/wt = 1 ± 0.05, Pclowt/gt = 1.05 ± 0.15, Pclogt/gt = 0.83 ± 0.12; three independent experiments; Dynamin : Pclowt/wt = 1 ± 0.11, Pclowt/gt = 1.44 ± 0.16, Pclogt/gt = 1.17 ± 0.05; three independent experiments). (H) Immunocytochemical staining of hippocampal neurons with antibodies against Homer, VGlut1 and MAP2 reveal the presence of VGlut1/Homer positive synapses along MAP2 positive dendrites in Pclowt/wt and Pclogt/gt neurons. (I) Images, of hippocampal neurons immunostained with antibodies against Synapsin and MAP2. The number of Synapsin positive puncta along primary dendrites (MAP2) does not differ between Pclowt/wt and Pclogt/gt neurons (left panel, Pclowt/wt = 0.27 ± 0.02, n = 27 primary dendrites; Pclogt/gt = 0.29 ± 0.02, n = 22 primary dendrites; two independent experiments). Scale bar in E, H and I 10 μm, scale bar in F 50 μm. Error bars in bar graph represent 95% confidence intervals. Numbers given represent mean ± SEM, Students T-test. **** denotes p<0.0001.10.7554/eLife.46629.004Figure 1—source data 1.This spreadsheet contains the normalized values used to generate the bar plots shown in Figure 1E,G and I.This spreadsheet contains the normalized values used to generate the bar plots shown in Figure 1E,G and I.Levels of synaptic vesicle proteins are reduced at Pclogt/gt synapses.(A) Immunocytochemical staining of cultured hippocampal neurons for SV proteins Synaptophysin, VGlut1, Synaptotagmin and Synapsin. The intensities of Synaptophysin, VGlut1 and Synaptotagmin are reduced in Pclogt/gt synapses. The levels of Synapsin, are not altered between Pclowt/wt and Pclogt/gt boutons. (B) Quantification of (A). (Synapotphysin : Pclowt/wt = 1.00 ± 0.01, n = 3457 puncta; Pclogt/gt = 0.81 ± 0.01, n = 2916 puncta; 13 independent experiments; VGlut1 : Pclowt/wt = 1.00 ± 0.02, n = 1907 puncta; Pclogt/gt = 0.70 ± 0.01, n = 2098 puncta; five independent experiments; Synaptotagmin : Pclowt/wt = 1.00 ± 0.01, n = 1987 puncta; Pclogt/gt = 0.69 ± 0.01, n = 1734 puncta; three independent experiments; Synapsin : Pclowt/wt = 1.00 ± 0.01, n = 2773 puncta; Pclogt/gt = 0.99 ± 0.01, n = 1848 puncta; four independent experiments). Scale bars represent 10 μm. Error bars in bar graph represent 95% confidence intervals. Numbers given represent mean ± SEM. Student's t-test. **** denotes p<0.0001.
false
Related conjugates and formulations (2)
-
HRP Anti-Dynamin 1 antibody [EP801Y]
-
Anti-Dynamin 1 antibody [EP801Y] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Dynamin 1 helps regulate synaptic transmission by controlling vesicular traffic in neurons. As part of a larger protein complex it interacts with various proteins to mediate endocytosis specifically in presynaptic nerve terminals. These interactions ensure that synaptic vesicles are recycled rapidly allowing neurons to maintain communication across synapses. Disruptions in dynamin 1 function can impair synaptic vesicle recycling affecting neurotransmission efficiency.
Pathways
Dynamin 1 is essential in the clathrin-mediated endocytic pathway. This pathway is a major route for internalizing synaptic vesicles and involves cooperation with other proteins such as clathrin and adaptor proteins. Additionally dynamin 1 participates in the actin cytoskeleton dynamics linking it with actin-associated proteins. These pathways highlight its contributions to maintaining synaptic vesicle endocytosis and neurite outgrowth processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (17)
Recent publications for all applications. Explore the full list and refine your search
Experimental & molecular medicine 54:1423-1433 PubMed35501375
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 8:175 PubMed35393410
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:680 PubMed35115539
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 36:109513 PubMed34407417
2021
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 34:16449-16463 PubMed33070431
2020
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 10:12827 PubMed32732936
2020
Applications
Unspecified application
Species
Unspecified reactive species
Medical science monitor : international medical jo 26:e923359 PubMed32573516
2020
Applications
Unspecified application
Species
Unspecified reactive species
eLife 8: PubMed31074746
2019
Applications
Unspecified application
Species
Unspecified reactive species
Neurobiology of disease 127:512-526 PubMed30954703
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neurogenetics 32:267-278 PubMed30484390
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com